Clinical Research Services Turku CRST Oy
- Address
- lock Available on a paid plan
Analytical, Diagnostic and Therapeutic Techniques
The site advances diagnostic imaging and biomarker platforms to support early detection and monitoring across several disease areas.
- Use of advanced PET imaging for neurodegenerative conditions
- Development of blood‑based biomarkers for cognitive decline
- Optimisation of MRI protocols in multiple sclerosis trials
Clinical Research Services Turku CRST Oy leverages these tools to improve trial precision and patient outcomes.
Digestive System Diseases
Research at the Turku centre focuses on disorders of the gastrointestinal tract, especially celiac disease and related gluten‑sensitivity conditions.
- Evaluation of novel agents that reduce celiac disease symptoms
- Assessment of intestinal mucosal healing after gluten challenge
- Studies on dietary adherence and quality of life in gluten‑free diets
The programme aims to provide better therapeutic options for patients struggling with persistent gastrointestinal issues.
Immune System Diseases
The Turku site conducts trials targeting autoimmune conditions, including psoriasis and multiple sclerosis.
- Dose‑finding studies for new biologics in mild‑to‑moderate psoriasis
- Evaluation of subcutaneous antibodies for relapsing multiple sclerosis
- Investigation of immune‑modulating pathways in inflammatory skin disorders
These efforts support the development of treatments that modulate the immune response while preserving safety.
Neoplasms
Oncology research at the facility centers on advanced prostate cancer, specifically metastatic castration‑resistant prostate cancer.
- Testing of investigational radiopharmaceuticals for tumor targeting
- Combination therapy safety and efficacy assessments
- Biomarker‑driven patient selection strategies
The goal is to expand therapeutic options for patients with aggressive disease forms.
Nervous System Diseases
Trials address a range of neurological disorders, from Alzheimer's disease to Parkinson's disease and narcolepsy.
- Interventions aimed at slowing cognitive decline in early Alzheimer’s
- Neuroprotective agents for Parkinson’s disease symptom management
- Safety and efficacy studies of novel treatments for narcolepsy
Clinical Research Services Turku CRST Oy seeks to improve functional outcomes for patients living with neuro‑degenerative conditions.
Skin and Connective Tissue Diseases
Focused research on dermatological conditions highlights psoriasis as a key indication.
- Phase studies to determine optimal dosing for new topical or systemic agents
- Patient‑reported outcome measures evaluating skin‑related quality of life
- Long‑term safety monitoring of emerging immunotherapies
The program aims to bring effective and well‑tolerated treatments to individuals affected by chronic skin disease.
Mental Disorders
Mental health research includes investigations of major depressive disorder, schizophrenia and related cognitive impairments.
- Adjunctive therapies for depression with inadequate response to standard antidepressants
- Cognitive function assessments in patients with schizophrenia
- Exploration of kappa‑opioid receptor antagonists for mood improvement
These studies aim to enhance therapeutic options and improve daily functioning for people living with mental illness.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 23 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
- 1Biogen Idec Research Limited1active
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +7 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 107 other sites in Finland
Therapeutic Area Benchmark — Finland
Select a therapeutic area to compare against other sites in Finland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Finland
Market Share
Country: Finland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinical Research Services Turku CRST Oy
lock Showing 1 of 29 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study) | Arctic Bioscience AS | Phase II | Not Recruiting | Mar 2023 | Mar 2025 |
IMP list
lock Showing 1 of 23 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Florbetaben (18F) | 3 | Unknown | 2023-09-28 | 2024-05-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.